Breast–Ovarian Hereditary Cancer Syndrome: Beyond BRCA1 and BRCA2

Evgeny Imyanitov, Anna Sokolenko · 2026

Read Breast–Ovarian Hereditary Cancer Syndrome: Beyond BRCA1 and BRCA2 by Evgeny Imyanitov, Anna Sokolenko (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13605284.txt.

Description

Evgeny Imyanitov and Anna Sokolenko review inherited breast and ovarian cancer genes beyond the famous pair in a 2026 paper. BRCA1 and BRCA2 anchor genetic testing, but other genes carry proven or likely risk. Knowing which ones matter guides both screening and drug choice.

PALB2 raises breast cancer risk strongly, while three other genes lean toward ovarian cancer. Some findings steer therapy: several gene faults make tumors sensitive to PARP-blocking drugs, and one points toward AKT-lowering drugs. Other listed genes only double risk or less. Rare double faults can cause severe disease needing intensive care. The authors expect wide gene panels to dominate testing, which makes careful reading of results ever more important.

Catalog record

CREATOREvgeny Imyanitov, Anna Sokolenko
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13605284

Browse the full library · About the Tower of Babel